CIK: 0001019231 · Show all filings
Period: Q2 2018 (← Previous) (Next →)
Filing Date: Aug 7, 2018
Total Value ($000): $259,708 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TRUST | 872,645 | $236,731 | 91.2% | $263.15 | — | ETFS | 78462F103 |
| — | AEGLEA BIOTHERAPEUTICS INC | 340,679 | $3,604 | 1.4% | $6.41 | — | COM | 00773J103 |
| TXN | TEXAS INSTRUMENTS INC | 32,000 | $3,528 | 1.4% | $56.41 | +54.7% | COM | 882508104 |
| VEA | VANGUARD FTSE DEV MKTS | 76,600 | $3,286 | 1.3% | $38.86 | — | ETFS | 921943858 |
| VOO | VANGUARD 500 INDEX FUND | 12,561 | $3,134 | 1.2% | $185.47 | — | ETFS | 922908363 |
| VOE | VANGUARD MID-CAP VALUE ETF | 27,538 | $3,042 | 1.2% | $87.03 | — | ETFS | 922908512 |
| VWO | VANGUARD MSCI EMERGING MKTS | 58,881 | $2,485 | 1.0% | $38.71 | — | ETFS | 922042858 |
| VDE | VANGUARD ENERGY ETF | 11,773 | $1,237 | 0.5% | $111.00 | — | ETFS | 92204A306 |
| VNQ | VANGUARD REIT ETF | 10,581 | $862 | 0.3% | $73.67 | — | ETFS | 922908553 |
| — | BIO-PATH HOLDINGS INC | 383,089 | $571 | 0.2% | $2.00 | — | COM | 09057N201 |
| — | APOLLO ENDOSURGERY INC | 68,293 | $477 | 0.2% | $12.52 | — | COM | 03767D108 |
| LXRX | LEXICON PHARMACEUTICALS INC | 35,714 | $429 | 0.2% | $7.34 | +39.3% | COM | 528872302 |
| — | PLX PHARMA INC | 62,673 | $244 | 0.1% | $6.14 | — | COM | 72942A107 |
| GILD | GILEAD SCIENCES | 850 | $60 | 0.0% | $52.72 | 0.0% | COM | 375558103 |
| POR | PORTLAND GENERAL ELECTRIC CO | 118 | $5 | 0.0% | $20.00 | +52.7% | COM | 736508847 |
| IWO | ISHARES TR RUSSELL 2000 GROWTH INDEX | 23 | $5 | 0.0% | $217.39 | — | ETFS | 464287648 |
| IJH | ISHARES S&P MIDCAP 400 INDEX ETF | 25 | $5 | 0.0% | $200.00 | — | ETFS | 464287507 |
| VZ | VERIZON COMMUNICATIONS INC | 54 | $3 | 0.0% | $32.21 | 0.0% | COM | 92343V104 |